I bring up Regeneron bc of its popularity recently. Clearly we’ve decided to pay LOTS of money for Regeneron. And with fluvoxamine… it’s generic and dirt cheap. So if we keep that same standard… fluvoxamine certainly looks reasonable. And remdesivir 👎: ht
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
RT @CochraneLibrary: 🤓Read the full @CochraneHaem systematic review and plain language summary: https://t.co/ntgfDQjMqs 💬Read the author…
RT @Roses_Parker: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 da…
For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days after treatment) versus placebo or usual care. We are uncertain about the effects of remdesivir on clinical improvement & worsen
RT @Students4BE: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 day…
For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days after treatment) versus placebo or usual care. We are uncertain about the effects of remdesivir on clinical improvement & worsen
RT @TheSGEM: Remdesivir for #COVID19 @cochranecollab “we are moderately certain that remdesivir probably has little or no effect on all-…
RT @CochraneLibrary: New #CochraneClinicalAnswer - What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/P5WBNpPk…
RT @CochraneLibrary: New #CochraneClinicalAnswer - What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/P5WBNpPk…
RT @CochraneLibrary: New #CochraneClinicalAnswer - What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/P5WBNpPk…
With moderate to severe #COVID‐19 #remdesivir led to - little to no difference in mortality. - fewer people required mechanical ventilation. - fewer people experienced grade 3/4 or serious adverse event.
New #CochraneClinicalAnswer - What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/P5WBNpPkWs Based on the systematic review https://t.co/xbCopfurck #openaccess https://t.co/gQ6a3QFGab
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
レムデシビルのレビューも日本語訳されてたけど、こっちについては某薬剤のものと違ってツイートは随分とあっさりした記述に留まってますね。まあ私にはこの結果を解釈するための知識はありませんが。 https://t.co/odxkur2VdP
RT @Students4BE: Is #remdesivir an effective treatment for #COVID19? https://t.co/vCt5ZB0ypd This @CochraneHaem systematic review looked at…
RT @Students4BE: Is #remdesivir an effective treatment for #COVID19? https://t.co/vCt5ZB0ypd This @CochraneHaem systematic review looked at…
Is #remdesivir an effective treatment for #COVID19? https://t.co/vCt5ZB0ypd This @CochraneHaem systematic review looked at this antiviral medicine to see if it's an effective treatment for people in hospital w #COVID & if it causes unwanted effects.
Im neuen Cochrane Review zu #Remdesivir wurden RCTs zur Wirksamkeit ausgewertet. "... Remdesivir probably has little or no effect on all‐cause mortality at up to 28 days in hospitalised adults with SARS‐CoV‐2 infection." https://t.co/bEXqGelhd8
RT @KarolPrillwitz: @greendisease88 @andy_wilinski To pomysł sobie co gdyby zamiast remdesiviru stasowano inwermektyne. https://t.co/0YZd0…
@VacekTom @jiri_hirs @VojtechGibis „Na základě v současnosti dostupných důkazů má remdesivir pravděpodobně malý nebo žádný vliv na úmrtnost ze všech příčin po dobu až 28 dnů u hospitalizovaných dospělých s infekcí SARS-CoV-2.“ https://t.co/gOf1e1Fv0G
@Lubomr12663547 @marekproksa @josef_judr @lubomir_volny "Zabíjí nepodáním léků na SarsCov2 lidí." Lháři. „Na základě v současnosti dostupných důkazů má remdesivir pravděpodobně malý nebo žádný vliv na úmrtnost ze všech příčin po dobu až 28 dnů u hospitaliz
@yul4yul „Na základě v současnosti dostupných důkazů má remdesivir pravděpodobně malý nebo žádný vliv na úmrtnost ze všech příčin po dobu až 28 dnů u hospitalizovaných dospělých s infekcí SARS-CoV-2.“ https://t.co/gOf1e1Fv0G
@VacekTom @jiri_hirs @VojtechGibis „Na základě v současnosti dostupných důkazů má remdesivir pravděpodobně malý nebo žádný vliv na úmrtnost ze všech příčin po dobu až 28 dnů u hospitalizovaných dospělých s infekcí SARS-CoV-2.“ https://t.co/gOf1e1Fv0G
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
RT @CochraneUK: New #CochraneClinicalAnswer: What are the effects of #remdesivir for the treatment of #COVID19? https://t.co/o4xNYSDH3u…
@greendisease88 @andy_wilinski To pomysł sobie co gdyby zamiast remdesiviru stasowano inwermektyne. https://t.co/0YZd0qhOzP
RT @TheSGEM: Remdesivir for #COVID19 @cochranecollab “we are moderately certain that remdesivir probably has little or no effect on all-…
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
RT @TheSGEM: Remdesivir for #COVID19 @cochranecollab “we are moderately certain that remdesivir probably has little or no effect on all-…
RT @TheSGEM: Remdesivir for #COVID19 @cochranecollab “we are moderately certain that remdesivir probably has little or no effect on all-…
RT @RockyJedickMD: As expected. Once you get COVID, dexamethasone seems to still be the best we got! #preventionfirst #getvaccinated #now
Remdesivir for #COVID19 @cochranecollab “we are moderately certain that remdesivir probably has little or no effect on all-cause mortality at up to day 28 in hospitalised adults with SARS-CoV-2 infection. “ @NightShiftMD https://t.co/FkPSAqxQp3
@concert_1750 まあ、皆さんそんな認識なんだよね。 感染症研の文献レビュー見てたらコクランレポートが目に入って、レムデシビルも重症化予防効果なしに入ってましてね、かなりヤバいよね。 https://t.co/6z1tlsrw2L
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
RT @CochraneLibrary: JUST PUBLISHED - Is #remdesivir an effective treatment for #COVID19? https://t.co/ntgfDQjMqs This @CochraneHaem system…
RT @CochraneLibrary: JUST PUBLISHED - Is #remdesivir an effective treatment for #COVID19? https://t.co/ntgfDQjMqs This @CochraneHaem system…
As expected. Once you get COVID, dexamethasone seems to still be the best we got! #preventionfirst #getvaccinated #now
RT @painfreeED: Remdesivir for the treatment of COVID-19. https://t.co/RjXh2vmvxa #FOAMed #MedEd #Covid_19
Remdesivir for the treatment of COVID‐19 - Ansems, K - 2021 | Cochrane Library https://t.co/WjhcRIfYM4
RT @painfreeED: Remdesivir for the treatment of COVID-19. https://t.co/RjXh2vmvxa #FOAMed #MedEd #Covid_19
Remdesivir for the treatment of COVID-19. https://t.co/RjXh2vmvxa #FOAMed #MedEd #Covid_19
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
RT @farma_gregorio: Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
Nueva revisión cochrane sobre la eficacia y seguridad de remdesivir en ensayos clínicos covid. https://t.co/ACU1UEsudf
Cochrane: “Remdesivirin hastaneye yatan erişkinlerde tüm sebeplerle 28 gün içinde gelişen mortaliteye çok az ya da hiç etkisi olmadığından orta düzeyde eminiz.” Bunu da aldım yatarken ama kortizon iğnesi bi başkaydı. Oyum ona https://t.co/1l5yo2UPRQ
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
@colemanjj As expected.
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
保険適応…
COVID-19感染者の治療に使用するレムデシビル https://t.co/qiJ7CcGPAv 読み通りです
RT @czcochrane: Je remdesivir účinnou léčbou proti onemocnění COVID-19? Dozvíte se v překladu souhrnu Cochrane SR na našem webu: https://t.…
RT @cochrane_nz: Is #remdesivir an effective treatment for #COVID19? https://t.co/yxkr1dg4SX This @CochraneHaem systematic review looked at…
RT @cochrane_nz: Is #remdesivir an effective treatment for #COVID19? https://t.co/yxkr1dg4SX This @CochraneHaem systematic review looked at…
¿Adivinen que te dan en México en las instituciones de salud? También fue aprobado de emergencia y en pocas palabras, no sirve.
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
Is #remdesivir an effective treatment for #COVID19? https://t.co/yxkr1dg4SX This @CochraneHaem systematic review looked at this antiviral medicine to see if it's an effective treatment for people in hospital w #COVID & if it causes unwanted effects. ht
>レムデシビルは治療後28日までのあらゆる原因による死亡に対して、おそらくほとんど、あるいは全く効果がない。
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
まとめると、コロナには効かないし副作用もない。で、おk? COVID-19感染者の治療に使用するレムデシビル https://t.co/9nftbll6t0
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @CochraneJapan: COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
COVID-19感染者の治療に使用するレムデシビル https://t.co/ZsgINjTx8S
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @czcochrane: Je remdesivir účinnou léčbou proti onemocnění COVID-19? Dozvíte se v překladu souhrnu Cochrane SR na našem webu: https://t.…
Je remdesivir účinnou léčbou proti onemocnění COVID-19? Dozvíte se v překladu souhrnu Cochrane SR na našem webu: https://t.co/5Dm2eL8Zu3 Read the full systematic review (Remdesivir for the treatment of COVID‐19) in the Cochrane Library: https://t.co/K8Szk
RT @CochraneLibrary: Kelly Ansems, @CochraneHaem: "Remdesivir probably has little or no effect on all-cause mortality at up to 28 days in h…
RT @CochraneLibrary: JUST PUBLISHED - Is #remdesivir an effective treatment for #COVID19? https://t.co/ntgfDQjMqs This @CochraneHaem system…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
コクランライブラリーからレムデシビルに厳しい評価 推してるのはACTTに関与するNIHと厚労省だけ🙄 https://t.co/H3Ceuk5Sju
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…
RT @CochraneLibrary: Kelly Ansems, @CochraneHaem: "Remdesivir probably has little or no effect on all-cause mortality at up to 28 days in h…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @sefh_: Revisión @cochranecollab sobre #remdesivir para tratamiento COVID-19 (agosto 2021) ❌Según evidencia actual, remdesivir probable…
RT @CochraneUK: For adults in hospital with #COVID19, #remdesivir probably has little or no effect on deaths (from any cause, up to 28 days…